The THL facility is able to embed, section, stain and scan FFPE and FF tissue for both research and clinical use. This can involve using already optimised antibodies, or establishing new protocols to GCP standard required for non-exploratory trial outcomes. Some examples of the projects that we have worked on are summarised below.
- Metabolic profiles of breast cancer linked to response to metformin treatmentOctober 2, 2018 - 1:42 pm
- AstraZeneca – Oxford Cancer Symposium (AZOCS), Thursday 13th September 2018 | Keble College, OxfordSeptember 20, 2018 - 1:57 pm
- Pioneering Combination Therapy Approach to Treating Colorectal CancerAugust 20, 2018 - 11:11 am